ZOSANO PHARMA CORP's ticker is ZSAN and the CUSIP is 98979H202. A total of 20 filers reported holding ZOSANO PHARMA CORP in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $45,000 | -52.1% | 199,497 | 0.0% | 0.00% | – |
Q4 2021 | $94,000 | -34.7% | 199,497 | 0.0% | 0.00% | – |
Q3 2021 | $144,000 | -24.2% | 199,497 | 0.0% | 0.00% | – |
Q2 2021 | $190,000 | -23.1% | 199,497 | 0.0% | 0.00% | – |
Q1 2021 | $247,000 | +263.2% | 199,497 | +53.5% | 0.00% | – |
Q4 2020 | $68,000 | -64.8% | 129,940 | +9.3% | 0.00% | – |
Q3 2020 | $193,000 | +124.4% | 118,881 | +17.9% | 0.00% | – |
Q2 2020 | $86,000 | +196.6% | 100,814 | +93.0% | 0.00% | – |
Q1 2020 | $29,000 | +16.0% | 52,238 | +221.4% | 0.00% | – |
Q4 2019 | $25,000 | 0.0% | 16,252 | 0.0% | 0.00% | – |
Q3 2019 | $25,000 | -52.8% | 16,252 | 0.0% | 0.00% | – |
Q2 2019 | $53,000 | -32.1% | 16,252 | 0.0% | 0.00% | – |
Q1 2019 | $78,000 | +32.2% | 16,252 | -41.7% | 0.00% | – |
Q4 2018 | $59,000 | -48.2% | 27,891 | 0.0% | 0.00% | – |
Q3 2018 | $114,000 | -4.2% | 27,891 | -4.3% | 0.00% | – |
Q2 2018 | $119,000 | – | 29,138 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 2,718,226 | $612,000 | 0.33% |
Telemetry Investments, L.L.C. | 210,000 | $47,000 | 0.07% |
Highlander Capital Management, LLC | 21,000 | $5,000 | 0.00% |
JOURNEY STRATEGIC WEALTH LLC | 20,000 | $5,000 | 0.00% |
STATE STREET CORP | 436,338 | $98,000 | 0.00% |
AVANTAX ADVISORY SERVICES, INC. | 10,000 | $2,000 | 0.00% |
CITIGROUP INC | 124,700 | $28,000 | 0.00% |
North Star Investment Management Corp. | 25,000 | $6,000 | 0.00% |
MORGAN STANLEY | 118,962 | $27,000 | 0.00% |
NATIONAL BANK OF CANADA /FI/ | 9,800 | $2,000 | 0.00% |